Name
As of 06/02/2026Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
11.5%
1 yr return
24.2%
3 Yr Avg Return
17.1%
5 Yr Avg Return
9.9%
Net Assets
$4.17 B
Holdings in Top 10
28.5%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 1.04%
SALES FEES
Front Load 5.75%
Deferred Load N/A
TRADING FEES
Turnover 54.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$1,000
IRA
$250
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 06/02/2026Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
LGVAX - Profile
Distributions
- YTD Total Return 11.5%
- 3 Yr Annualized Total Return 17.1%
- 5 Yr Annualized Total Return 9.9%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio 0.73%
- Dividend Yield 1.3%
- Dividend Distribution Frequency None
Fund Details
-
Legal NameClearBridge Value Fund
-
Fund Family NameFRANKLIN TEMPLETON
-
Inception DateFeb 03, 2009
-
Shares OutstandingN/A
-
Share ClassA
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerSam Peters
Fund Description
LGVAX - Performance
Return Ranking - Trailing
| Period | LGVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 11.5% | -6.3% | 48.0% | 29.28% |
| 1 Yr | 24.2% | -0.8% | 92.5% | 42.50% |
| 3 Yr | 17.1%* | -0.2% | 43.3% | 49.11% |
| 5 Yr | 9.9%* | 0.2% | 25.0% | 48.44% |
| 10 Yr | 12.0%* | 4.0% | 27.7% | 25.68% |
* Annualized
Return Ranking - Calendar
| Period | LGVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2025 | -0.2% | -43.6% | 32.4% | 83.21% |
| 2024 | 4.3% | -34.7% | 47.5% | 57.19% |
| 2023 | 5.7% | -16.9% | 46.1% | 51.26% |
| 2022 | -13.6% | -43.2% | 4.6% | 66.56% |
| 2021 | 7.2% | -44.1% | 57.5% | 85.75% |
Total Return Ranking - Trailing
| Period | LGVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 11.5% | -6.3% | 48.0% | 29.28% |
| 1 Yr | 24.2% | -0.8% | 92.5% | 42.50% |
| 3 Yr | 17.1%* | -0.2% | 43.3% | 49.11% |
| 5 Yr | 9.9%* | 0.2% | 25.0% | 48.44% |
| 10 Yr | 12.0%* | 4.0% | 27.7% | 25.68% |
* Annualized
Total Return Ranking - Calendar
| Period | LGVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2025 | 10.5% | -0.4% | 32.7% | 87.20% |
| 2024 | 15.2% | -17.4% | 47.5% | 41.13% |
| 2023 | 19.4% | -15.9% | 46.7% | 8.09% |
| 2022 | -6.4% | -42.0% | 8.5% | 57.54% |
| 2021 | 28.1% | 6.9% | 129.7% | 27.75% |
NAV & Total Return History
LGVAX - Holdings
Concentration Analysis
| LGVAX | Category Low | Category High | LGVAX % Rank | |
|---|---|---|---|---|
| Net Assets | 4.17 B | 2.59 M | 238 B | 28.44% |
| Number of Holdings | 71 | 2 | 1671 | 59.92% |
| Net Assets in Top 10 | 1.16 B | 603 K | 47.6 B | 28.33% |
| Weighting of Top 10 | 28.54% | 4.5% | 99.2% | 46.27% |
Top 10 Holdings
- Alphabet Inc 4.58%
- Bank of America Corp 3.54%
- Micron Technology Inc 3.47%
- Johnson Johnson 3.27%
- Chevron Corp 2.61%
- Amazon.com Inc 2.59%
- EQT Corp 2.35%
- Walt Disney Co/The 2.15%
- Gilead Sciences Inc 1.99%
- CVS Health Corp 1.97%
Asset Allocation
| Weighting | Return Low | Return High | LGVAX % Rank | |
|---|---|---|---|---|
| Stocks | 98.98% | 3.70% | 130.75% | 39.03% |
| Cash | 1.02% | 0.00% | 26.41% | 55.51% |
| Preferred Stocks | 0.00% | 0.00% | 22.62% | 30.64% |
| Other | 0.00% | -1.51% | 19.37% | 43.02% |
| Convertible Bonds | 0.00% | 0.00% | 3.66% | 28.12% |
| Bonds | 0.00% | 0.00% | 127.82% | 29.70% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | LGVAX % Rank | |
|---|---|---|---|---|
| Financial Services | 22.93% | 0.00% | 58.05% | 19.62% |
| Healthcare | 15.77% | 0.00% | 27.67% | 66.88% |
| Energy | 14.54% | 0.00% | 54.00% | 5.80% |
| Technology | 13.98% | 0.00% | 54.02% | 23.84% |
| Consumer Cyclical | 7.45% | 0.00% | 22.74% | 28.38% |
| Industrials | 6.60% | 0.00% | 42.76% | 89.77% |
| Basic Materials | 6.06% | 0.00% | 20.01% | 10.97% |
| Utilities | 4.82% | 0.00% | 27.04% | 44.51% |
| Communication Services | 4.02% | 0.00% | 26.58% | 73.73% |
| Consumer Defense | 2.82% | 0.00% | 34.10% | 93.88% |
| Real Estate | 0.99% | 0.00% | 90.54% | 74.16% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | LGVAX % Rank | |
|---|---|---|---|---|
| US | 93.47% | 3.70% | 130.75% | 80.27% |
| Non US | 5.51% | 0.00% | 27.70% | 12.07% |
LGVAX - Expenses
Operational Fees
| LGVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 1.04% | 0.03% | 7.64% | 36.46% |
| Management Fee | 0.64% | 0.00% | 1.50% | 66.21% |
| 12b-1 Fee | 0.25% | 0.00% | 1.00% | 31.45% |
| Administrative Fee | N/A | 0.01% | 0.50% | N/A |
Sales Fees
| LGVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | 5.75% | 1.00% | 5.75% | 13.85% |
| Deferred Load | N/A | 0.95% | 4.00% | N/A |
Trading Fees
| LGVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| LGVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 54.00% | 0.00% | 240.00% | 69.89% |
LGVAX - Distributions
Dividend Yield Analysis
| LGVAX | Category Low | Category High | LGVAX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 1.31% | 0.00% | 16.67% | 3.26% |
Dividend Distribution Analysis
| LGVAX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | None | Annual | Quarterly | Quarterly |
Net Income Ratio Analysis
| LGVAX | Category Low | Category High | LGVAX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | 0.73% | -1.51% | 4.28% | 81.05% |
Capital Gain Distribution Analysis
| LGVAX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Semi-Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Dec 11, 2025 | $1.372 | OrdinaryDividend |
| Dec 11, 2025 | $8.773 | CapitalGainLongTerm |
| Dec 12, 2024 | $10.217 | OrdinaryDividend |
| Dec 12, 2024 | $0.821 | OrdinaryDividend |
| Dec 12, 2024 | $0.312 | CapitalGainShortTerm |
| Dec 12, 2024 | $9.084 | CapitalGainLongTerm |
| Dec 13, 2023 | $1.402 | OrdinaryDividend |
| Dec 13, 2023 | $1.050 | CapitalGainShortTerm |
| Dec 13, 2023 | $8.983 | CapitalGainLongTerm |
| Dec 13, 2022 | $7.267 | OrdinaryDividend |
| Dec 03, 2021 | $17.945 | OrdinaryDividend |
| Jun 17, 2021 | $0.324 | CapitalGainLongTerm |
| Dec 04, 2020 | $5.550 | OrdinaryDividend |
| Dec 05, 2019 | $0.472 | OrdinaryDividend |
| Dec 06, 2018 | $0.912 | CapitalGainShortTerm |
| Dec 06, 2018 | $0.385 | OrdinaryDividend |
| Dec 06, 2017 | $0.405 | OrdinaryDividend |
| Dec 07, 2016 | $0.664 | OrdinaryDividend |
| Dec 09, 2015 | $0.248 | OrdinaryDividend |
| Dec 10, 2014 | $0.231 | OrdinaryDividend |
| Dec 26, 2013 | $0.557 | OrdinaryDividend |
| Dec 12, 2012 | $0.623 | OrdinaryDividend |
| Dec 28, 2011 | $0.297 | OrdinaryDividend |
| Dec 10, 2009 | $0.334 | OrdinaryDividend |
LGVAX - Fund Manager Analysis
Managers
Sam Peters
Start Date
Tenure
Tenure Rank
Nov 01, 2010
11.59
11.6%
• Member of the CFA Institute • Industry since 1993 • Firm since 2005 • University of Chicago — MBA • College of William & Mary — BA in Economics • Fidelity Management & Research - Portfolio Manager, Health Care Sector Team Leader • Samuel M. Peters Investment Advisors - Founder • Eppler, Guerin & Turner - Financial Consultant - See more at: https://www.clearbridge.com/about/team/portfolio-management/peters-sam.html?team=portfolio_management#sthash.9Ysk0KIZ.dpuf
Jean Yu
Start Date
Tenure
Tenure Rank
May 15, 2013
9.05
9.1%
Jean Yu, CFA, PhD Managing Director, Portfolio Manager Experience: 14 years of investment industry experience Joined ClearBridge, LLC (f/k/a Legg Mason Capital Management, LLC) in 2002 Member of the CFA Institute ISO Health Care Group - Senior Business Analyst PhD in Molecular Biology from Columbia University MBA in Health Sector Management and Finance from Duke University MD from Beijing Medical University
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.13 | 86.59 | 8.32 | 6.71 |